LATIN AMERICA
Latin America includes a portfolio of locally recognised and trusted brands sold across the public and private sector. Brazil and Mexico are the biggest contributors to regional performance.
Key Countries
Brazil
Chile
Colombia
Ecuador
Mexico

- The Brazilian private pharmaceutical market declined 3%, negatively impacted by foreign exchange movements and was valued by IQVIA at USD26 billion, while the Brazilian pharmaceutical market in local currency grew 11% for the year 30 June 2020.
Source: IQVIA – June 2020
STATISTICS
Number of products launched:
6
(2019: 8)
Average staff turnover*:
27%
(2019: 25%)
Number of product recalls:
Nil
(2019: Nil)
Number of work-related fatalities:
Nil
(2019: Nil)
* Rate excludes employees transferred in Nutritionals disposal.
Number of permanent employees | ||
736June 2020 |
773June 2019 |
Revenue | 2020 R’million |
2019 (CER) R’million |
Change % |
||||
---|---|---|---|---|---|---|---|
Regional Brands | 2 342 | 2 136 | 10 | ||||
Sterile Focus Brands | 1 070 | 957 | 12 | ||||
Anaesthetics Brands | 994 | 882 | 13 | ||||
Thrombosis Brands | 76 | 75 | 1 | ||||
Total | 3 412 | 3 093 | 10 |
Note: Commercial Pharmaceuticals revenue is disclosed by customer geography.